Susquehanna International Group’s Nephros NEPH Stock Holding History

Susquehanna International Group’s Portfolio NEPH Stock Details NEPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,373	Closed	-$49.1K	–	13164
2025 Q3	$49.1K	Sell	10,373 -19,052	-65%	-$74.8K	﹤0.01%	11867
2025 Q2	$120K	Buy	29,425 +5,807	+25%	+$15.5K	﹤0.01%	11672
2025 Q1	$40.6K	Sell	23,618 -184	-0.8%	-$289	﹤0.01%	11924
2024 Q4	$34.8K	Buy	+23,802	New	+$36.3K	﹤0.01%	11806
2024 Q1	–	Sell	-11,784	Closed	-$40.7K	–	12940
2023 Q4	$40.7K	Buy	+11,784	New	+$25.6K	﹤0.01%	11792
2023 Q2	–	Sell	-35,990	Closed	-$39.2K	–	12771
2023 Q1	$39.2K	Buy	+35,990	New	+$41.4K	﹤0.01%	11804

Other funds holding NEPH

Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Susquehanna International Group's NEPH Position: Q4 2025 in Review

Susquehanna International Group sold out of Nephros (NEPH) in Q4 2025, closing a stake of 10,373 shares — an estimated $49.1K sold.

Susquehanna International Group first reported a position in NEPH in Q1 2023 and held it in 6 quarters. The position peaked at $120K in Q2 2025. 35 funds tracked by Wall St. Rank hold NEPH as of Q4 2025.

Susquehanna International Group reported no remaining Nephros position as of Q4 2025 after selling out during the quarter.
Susquehanna International Group sold 10,373 Nephros shares in Q4 2025, an estimated $49.1K.
Susquehanna International Group first reported a position in Nephros in Q1 2023 and held it in 6 quarters.
Susquehanna International Group's Nephros position peaked at $120K in Q2 2025.
35 funds tracked by Wall St. Rank held Nephros as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.